BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4998107)

  • 1. [Test of a new beta-blocking agent, LB 46, in the therapy of angina pectoris].
    Yigitbasi O; Nalbantgil I
    Schweiz Rundsch Med Prax; 1970 Aug; 59(34):1218-21. PubMed ID: 4998107
    [No Abstract]   [Full Text] [Related]  

  • 2. Alprenolol in angina pectoris. A clinical and ergometric study with a new beta-adrenergic blocking agent.
    Arstila M; Iisalo E; Kallio V
    Ann Clin Res; 1969 May; 1(1):13-21. PubMed ID: 4390794
    [No Abstract]   [Full Text] [Related]  

  • 3. A single blind trial of Trasicor (Ciba 39,089-Ba) in angina pectoris.
    Turner AS; Wilson DF
    Isr J Med Sci; 1969; 5(4):738-40. PubMed ID: 4980553
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of angina pectoris with cardioselective beta blocking agents. Double blind study with Eraldin (practolol)].
    Erikssen J; Rod T
    Tidsskr Nor Laegeforen; 1971 Apr; 91(10):721-5. PubMed ID: 4397025
    [No Abstract]   [Full Text] [Related]  

  • 5. Practolol in the treatment of ischaemic heart pain. Results of a controlled trial.
    Nestel PJ
    Med J Aust; 1972 May; 1(20):1033-5. PubMed ID: 4626799
    [No Abstract]   [Full Text] [Related]  

  • 6. [New adrenergic blocking agent Visken (LB-46) in the treatment of chronic coronary disease].
    Musial W; Tracz W; Krzemińska-Pakula M
    Pol Tyg Lek; 1971 May; 26(22):834-6. PubMed ID: 4397439
    [No Abstract]   [Full Text] [Related]  

  • 7. [Positive and negative effects of beta-adrenergic blocking in angina pectoris. (Indications on the contemporary use of nitroglycerin and aminophylline)].
    Starcich R; Barbaresi F; Volta G; Pavarani A
    Minerva Cardioangiol; 1967 Dec; 15(12):835-43. PubMed ID: 4975623
    [No Abstract]   [Full Text] [Related]  

  • 8. [Paradoxal reaction to beta-adrenergic blocking therapy of coronary angina].
    Dal Palù C; Gasparotto G; Stritoni P
    Boll Soc Ital Cardiol; 1967; 12(2):104-8. PubMed ID: 5606862
    [No Abstract]   [Full Text] [Related]  

  • 9. [Beta-blocking agents in angina pectoris. A double-blind trial].
    Aubert AB; Nyberg G; Slaastad R; Tjeldflaat L
    Tidsskr Nor Laegeforen; 1970 Feb; 90(4):409-13 passim. PubMed ID: 4393271
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of a new adrenergic beta receptor blocking drug and of nitroglycerin on angina attacks accompanied by unstable left branch block (1 case)].
    Vettori G; Magaraggia L
    Folia Cardiol; 1967; 26(6):351-6. PubMed ID: 4970028
    [No Abstract]   [Full Text] [Related]  

  • 11. [A new beta blocking agent: LB-46. Clinical use in the treatment of rhythm disorders and coronary insufficiency].
    Dutoit A; Lepoutre B; Leuridan B; Croccel L; Giard P
    J Sci Med Lille; 1972 Feb; 90(2):83-9. PubMed ID: 4403207
    [No Abstract]   [Full Text] [Related]  

  • 12. A new beta receptor blocking agent LB-46 in angina pectoris. (A double blind clinical trial).
    Srivastava BN; Jain PC; Vyas GP
    Indian Heart J; 1972 Jun; 24():Suppl 1:203-4. PubMed ID: 4581428
    [No Abstract]   [Full Text] [Related]  

  • 13. Alprenolol ("aptin") in angina pectoris. A double-blind multicentre trial.
    Hickie JB
    Med J Aust; 1970 Aug; 2(6):268-72. PubMed ID: 4393977
    [No Abstract]   [Full Text] [Related]  

  • 14. [The treatment of angina pectoris with beta receptor blockaders].
    Kaltenbach M; Becker HJ; Graef V; Hunscha H
    Med Klin; 1971 Mar; 65(11):494-500. PubMed ID: 4996983
    [No Abstract]   [Full Text] [Related]  

  • 15. [A new beta-blockader, LB-46 (Visken): electrocardiographic control of its therapeutic action in angina patients].
    Saner R
    Therapie; 1970; 25(2):393-501. PubMed ID: 4403159
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of LB-46 in angina pectoris and cardiac arrhythmias].
    Maranhão MF; da Cunha GP; Rojas RI
    Arq Bras Cardiol; 1972 Feb; 25(1):51-60. PubMed ID: 4403346
    [No Abstract]   [Full Text] [Related]  

  • 17. [Beta adrenergic receptor blocking agents in the treatment of arrhythmia and angina pectoris].
    Fülöp T; Szodoray P
    Orv Hetil; 1969 Oct; 110(41):2387-94. PubMed ID: 5358359
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical study of a new beta-blocking agent: LB 46].
    Warembourg H; Ducloux G
    Lille Med; 1971 Oct; 16():Suppl 4:1203-8. PubMed ID: 4399711
    [No Abstract]   [Full Text] [Related]  

  • 19. [Remote results of treatment of angina pectoris with various types of drugs blocking beta adrenergic receptors].
    Musial W; Krzemińska-Pakula M; Tracz W
    Pol Tyg Lek; 1972 May; 27(20):752-4. PubMed ID: 4402234
    [No Abstract]   [Full Text] [Related]  

  • 20. Results of the use of a new beta-adrenergic blocker (LB 46) in angina pectoris.
    Aravanis C; Michaelides G
    Acta Cardiol; 1970; 25(5):501-9. PubMed ID: 4395273
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.